Handok Inc (002390):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Handok Inc (002390) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3486
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Handok Inc (Handok), formerly Handok Pharmaceuticals Co Ltd is a pharmaceutical and health care company that manufactures, develops, and distributes healthcare solutions. The company develops and provides pharmaceutical products such as OTC drugs, medical devices, prescription drugs and in vitro diagnostics. It also provides The tritace, xatral XL, amaryl and amaryl M, teveten, festal nicostop and clearteen. Handok offers its prescription medicines for the treatment of diabetes, high blood pressure, harmone dificiency, hemophilia, cancer, skin ailments, ulcers, allergy and others. The company supplies its healthcare products for digestion, skin ointment, diuretics, anti-histamines, calcium, antibiotic pills and injections. It works in partnership with pharmaceutical companies. Handok is headquartered in Seoul, South Korea.

Handok Inc (002390) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Handok Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Handok Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Handok Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Handok Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Handok Inc, Medical Devices Deals, 2012 to YTD 2018 10
Handok Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Handok Inc, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Handok Enters into Agreement with Actelion Pharmaceuticals 12
Handok Enters into Agreement with Korea Roche 13
Handok Pharma Enters Into Co-Marketing Agreement With Novartis Korea For Onbrez Breezhaler 14
Handok Pharma Enters Into Co-Marketing Agreement With Nutricia For Nine Medical Nutrition Products 15
Teva Pharma To Form Joint Venture With Handok Pharma 16
Handok Enters Into Co-Marketing Agreement With Roche For Madopar 17
Taejoon Pharm Enters Into Co-Promotion Agreement With Handok Pharma For Gatiflo 18
Debt Offering 19
Handok Raises USD26.4 Million in Public Offering of Bonds 19
Acquisition 20
IMM Private Equity Sells 7.93% Stake in Handok for USD141.4 Million 20
Handok Acquires Theravalues from San-Eigen for USD18.4 Million 21
Handok Acquires Pacific Pharma for USD54.5 Million 22
Handok Inc – Key Competitors 23
Handok Inc – Key Employees 24
Handok Inc – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Handok Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Handok Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Handok Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Handok Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Handok Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Handok Inc, Medical Devices Deals, 2012 to YTD 2018 10
Handok Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Handok Enters into Agreement with Actelion Pharmaceuticals 12
Handok Enters into Agreement with Korea Roche 13
Handok Pharma Enters Into Co-Marketing Agreement With Novartis Korea For Onbrez Breezhaler 14
Handok Pharma Enters Into Co-Marketing Agreement With Nutricia For Nine Medical Nutrition Products 15
Teva Pharma To Form Joint Venture With Handok Pharma 16
Handok Enters Into Co-Marketing Agreement With Roche For Madopar 17
Taejoon Pharm Enters Into Co-Promotion Agreement With Handok Pharma For Gatiflo 18
Handok Raises USD26.4 Million in Public Offering of Bonds 19
IMM Private Equity Sells 7.93% Stake in Handok for USD141.4 Million 20
Handok Acquires Theravalues from San-Eigen for USD18.4 Million 21
Handok Acquires Pacific Pharma for USD54.5 Million 22
Handok Inc, Key Competitors 23
Handok Inc, Key Employees 24
Handok Inc, Other Locations 25
Handok Inc, Subsidiaries 25

List of Figures
Handok Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Handok Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Handok Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Handok Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Handok Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Handok Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Handok Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Handok Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Handok Inc, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Handok Inc (002390):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • NuGEN Technologies Inc-製薬・医療分野:企業M&A・提携分析
    Summary NuGEN Technologies Inc (NuGEN) is a provider of biological science reagents. The company offers DNA and RNA sample preparation products for use in research and diagnostic applications. Its products include Next-Gen Sequencing applications, which include RNA-Seq, targeted resequencing of DNA …
  • Enea AB (ENEA):企業の財務・戦略的SWOT分析
    Summary Enea AB (Enea) is a technology company that provides software products, services and solutions. The company’s product portfolio consists of NFV virtualization platforms, operating systems, device and network management, traffic intelligence, 5g data management, access management and policy c …
  • GenomicTree Co Ltd (228760):企業の製品パイプライン分析
    Summary GenomicTree Co Ltd (GenomicTree) is a medical device company that develops and commercializes diagnostic products for the screening and diagnosis of cancer. The company also provides non-invasive cancer molecular diagnostic product. Its products are used in the detection of colorectal, lung …
  • Damco International A/S:戦略・SWOT・企業財務分析
    Damco International A/S - Strategy, SWOT and Corporate Finance Report Summary Damco International A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Osprey Medical Inc (OSP):企業の財務・戦略的SWOT分析
    Summary Osprey Medical Inc (Osprey Medical) is a medical device company that designs, develops, and manufacturers proprietary devices and monitoring systems. The company offers contrast removal system, which is designed to provide cardiologists with an advanced level of CIN protection in high risk p …
  • Amarin Corp Plc (AMRN):企業の財務・戦略的SWOT分析
    Amarin Corp Plc (AMRN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Infinity Energy Resources Inc (IFNY):石油・ガス:M&Aディール及び事業提携情報
    Summary Infinity Energy Resources Inc (Infinity Energy) is an oil and gas company that offers exploration and development of crude oil resources. The company operates oil and gas concessions located at offshore Nicaragua in the Caribbean Sea. Its concessions are located adjacent to Noble Energy’s of …
  • DEME NV:企業の戦略的SWOT分析
    DEME NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Personal Genome Diagnostics Inc:製品パイプライン分析
    Summary Personal Genome Diagnostics Inc (PGD) is a genomic solution provider. The company develops next-generation sequencing and proprietary algorithms to identify alterations in complex cancer genomes. It provides a portfolio of regulated tissue-based and liquid biopsy genomic products for laborat …
  • Hiscox Ltd:戦略・SWOT・企業財務分析
    Hiscox Ltd - Strategy, SWOT and Corporate Finance Report Summary Hiscox Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Matsumotokiyoshi Holdings Co Ltd:企業の戦略・SWOT・財務分析
    Matsumotokiyoshi Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Matsumotokiyoshi Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Steatite Limited:企業の戦略・SWOT・財務情報
    Steatite Limited - Strategy, SWOT and Corporate Finance Report Summary Steatite Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Curevac AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Curevac AG (Curevac), formerly CureVac GmbH is a clinical-stage biopharmaceutical company that develops RNA-based medicines. The company develops, designs, and produces messenger RNA molecules for therapeutic and prophylactic vaccines in the fields of oncology and infectious diseases. Its RN …
  • Dover Corp (DOV):企業の財務・戦略的SWOT分析
    Dover Corp (DOV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Beach Energy Ltd (BPT):石油・ガス:M&Aディール及び事業提携情報
    Summary Beach Energy Ltd (Beach Energy) is an independent upstream oil and gas company. It carries out the exploration, development, production, transportation and marketing of oil and natural gas. The company has core exploration and development drilling operations in the Cooper and Eromanga basins …
  • Melinta Therapeutics Inc (MLNT):企業の財務・戦略的SWOT分析
    Melinta Therapeutics Inc (MLNT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Bonavista Energy Corp (BNP):石油・ガス:M&Aディール及び事業提携情報
    Summary Bonavista Energy Corp (Bonavista) is an intermediate energy company, which acquires, explores for, develops and produces oil and natural gas from its assets in the provinces of Alberta, British Columbia and Saskatchewan. Its core operations are concentrated in the Glauconite and Falher plays …
  • Western Farmers Electric Cooperative:発電所・企業SWOT分析
    Western Farmers Electric Cooperative - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Imdex Ltd (IMD):石油・ガス:M&Aディール及び事業提携情報
    Summary Imdex Limited (Imdex) is a provider of integrated technological solutions to the mineral industry. The company offers drilling fluids, drilling equipment, advanced downhole instrumentation, data management solution and analytical software for geological modeling through its AMC and REFLEX br …
  • Seven Generations Energy Ltd (VII):企業の財務・戦略的SWOT分析
    Seven Generations Energy Ltd (VII) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆